)
Our featured content
Vi Partners announces first close of its new CHF 150 million fund
Vi Partners announces first close of Vi-26, its new CHF 150 million fund, marking 25 years of Swiss venture investing and, reinforcing its commitment to Swiss and European Tech and Healthcare.
)
iOnctura Launches Phase I/II Trial in Myelofibrosis
iOnctura has treated the first patient in a new clinical study evaluating a novel combination therapy for myelofibrosis. Early data to be presented at ASH show promising activity and support this next step in development.
)
Xeltis Raises Nearly €50m to Advance aXess Toward Market Approval
Xeltis secures major new financing from the European Investment Bank and existing shareholders to accelerate aXess toward market entry. The investment follows strong EU clinical results and marks a significant step in bringing this breakthrough hemodialysis therapy to patients.
)
Vi Partners Celebrates Nexthink’s $3B Valuation—A Landmark Swiss Tech Exit
Vi Partners celebrates a landmark exit with Nexthink as it reaches a $3 billion valuation. This success highlights the strength of Swiss innovation and long-term partnership.
)
Vara earns CE mark as Europe’s first independent AI reader in mammography
Vara’s breast-imaging AI is now the only solution authorized to act as an independent second reader for both screening and diagnostic use — a breakthrough that addresses Europe’s radiologist shortage and advances early cancer detection.
)
Unlocking Europe’s AI Revolution
AI is driving the steepest enterprise technology inflection since the cloud, transforming how businesses operate from factory floor to operating theatre. Our latest white paper explores how Europe, and particularly Switzerland, is positioned to lead this revolution across different verticals. Download the report to see where the next generation of AI-native leaders will emerge!
)
Latest News
-
Firm – Jan 21, 2026 )
Portfolio – Dec 05, 2025 iOnctura initiates Phase I/II trial in patients with myelofibrosis ahead of new nonclinical data at ASH
)
Portfolio – Dec 03, 2025 Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market
)
Entrepreneurs improve the world. We proudly support them.
Our heritage
Who we are and how we started
Vi Partners' founding team came together in 2000 to advise Venture Incubator, an investment vehicle initiated by ETHZ and funded by ten blue-chip Swiss companies. Today, we advise funds investing across Europe in tech and healthcare.
)